Table 4.
Peptide dose | No. | Course |
CTL response |
|||
---|---|---|---|---|---|---|
CDCA1 | CDH3 | KIF20A | Positive control | |||
1 mg |
1 |
Pre |
- |
+ |
- |
+++ |
Post 1 |
- |
- |
+ |
+++ |
||
Post 2 |
- |
- |
- |
+++ |
||
2 |
Pre |
- |
- |
- |
+++ |
|
Post 1 |
++ |
- |
+ |
+++ |
||
3 |
Pre |
+ |
- |
- |
+++ |
|
Post 1 |
NA* |
NA |
NA |
+++ |
||
Post 2 |
- |
+ |
- |
+++ |
||
Post 3 |
+ |
++ |
- |
+++ |
||
Post 4 |
+ |
- |
+ |
+++ |
||
2 mg |
4 |
Pre |
+ |
- |
+ |
+++ |
Post 1 |
- |
- |
+ |
+++ |
||
Post 2 |
+ |
- |
+ |
+++ |
||
Post 3 |
- |
- |
- |
+++ |
||
5 |
Pre |
- |
- |
- |
+++ |
|
Post 1 |
- |
- |
- |
+++ |
||
Post 2 |
- |
- |
+ |
+++ |
||
Post 3 |
+ |
- |
+++ |
+++ |
||
Post 4 |
- |
- |
++ |
+++ |
||
Post 5 |
+ |
+ |
- |
+++ |
||
Post 6 |
- |
- |
- |
+++ |
||
6 |
Pre |
- |
+ |
- |
+++ |
|
Post 1 |
+ |
+ |
- |
+++ |
||
Post 2 |
+ |
+ |
- |
+++ |
||
3 mg | 7 |
Pre |
NA |
NA |
NA |
+++ |
Post 1 |
- |
- |
- |
+++ |
||
Post 2 |
++ |
+ |
++ |
+++ |
||
8 |
Pre |
- |
- |
+ |
+++ |
|
Post 1 |
- |
+ |
- |
+++ |
||
Post 2 |
++ |
+ |
++ |
+++ |
||
Post 3 |
+++ |
+++ |
+ |
+++ |
||
Post 5 |
+++ |
+++ |
+++ |
+++ |
||
9 | Pre |
+ |
- |
+ |
+++ |
|
Post 1 |
++ |
+ |
+ |
+++ |
||
Post 2 |
- |
+ |
- |
+++ |
||
Post 3 |
- |
+++ |
+ |
+++ |
||
Post 4 |
++ |
- |
- |
+++ |
||
Post 6 | ++ | + | ++ | +++ |
*NA: not analyzed.